[1]CIOLOFAN MS,VLAESCU AN,MOGOANTA CA,et al.Clinical,histological and immunohistochemical evaluation of larynx cancer[J].Current Health Sciences Journal,2017,43(4):367-375.
[2]SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2022[J].CA:A Cancer Journal for Clinicians,2022,72(1):7-33.
[3]GAO W,GUO H,NIU M,et al.CircPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway[J].Molecular Cancer,2020,19(1):166.
[4]ADIL MS,KHULOOD D,SOMANATH PR.Targeting Akt-associated microRNAs for cancer therapeutics [J].Biochemical Pharmacology,2021,189(14):114384.
[5]LI J,TANG Z,WANG H,et al.CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p[J].Biomedicine & Pharmacotherapy,2018,97(1):1182-1188.
[6]ZHANG X,ZHOU J,XUE D,et al.MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer[J].International Journal of Biological Macromolecules,2019,129(5):227-232.
[7]NI JS,ZHENG H,OU YL,et al.MiR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway[J].Surgical Oncology,2020,34(3):113-120.
[8]TANG Y,CAI J,LYU B.LncRNA ubiquitin-binding protein domain protein 10 antisense RNA 1 inhibits colon adenocarcinoma progression via the miR-515-5p/slit guidance ligand 3 axis[J].Bioengineered,2022,13(2):2308-2320.
[9]QI F,TANG J,CAI Z,et al.Long non-coding RNA CATIP antisense RNA 1(lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition(EMT) pathway[J].Bioengineered,2022,13(3):7592-7606.
[10]DE BARROS E,LIMA BUENO R,RAMAO A,et al.HOX genes:potential candidates for the progression of laryngeal squamous cell carcinoma[J].Tumour Biology,2016,37(11):15087-15096.
[11]FENG L,WANG R,LIAN M,et al.Integrated analysis of long noncoding RNA and mRNA expression profile in advanced laryngeal squamous cell carcinoma[J].PLoS One,2016,11(12):e0169232.
[12]WU Y,ZHANG Y,ZHENG X,et al.Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis[J].Molecular Cancer,2020,19(1):99.
[13]LUO J,WU J,LI Z,et al.miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma[J].Biomed Research International,2014,2014:374598.
[14]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2016[J].CA:a Cancer Journal for Clinicians,2016, 66(1):7-30.
[15]KITAMURA N,SENTO S,YOSHIZAWA Y,et al.Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma[J].International Journal of Molecular Sciences,2020,22(1):240.
[16]HE B,ZHAO Z,CAI Q,et al.miRNA-based biomarkers,therapies,and resistance in cancer[J].International Journal of Biological Sciences,2020,16(14):2628-2647.
[17]YUAN XW,YAN TQ,TONG H.Effect of miR-515-5p on proliferation and drug sensitivity of retinoblastoma cells[J].Cancer Management and Research,2020,12:12087-12098.
[18]PARDO OE,CASTELLANO L,MUNRO CE,et al.MiR-515-5p controls cancer cell migration through MARK4 regulation[J].EMBO Reports,2016,17(4):570-584.
[19]LI M,CHEN WD,WANG YD.The roles of the gut microbiota-miRNA interaction in the host pathophysiology[J].Molecular Medicine,2020,26(1):101.
[20]AZIZIAN A,EPPING I,KRAMER F,et al.Prognostic value of microRNAs in preoperative treated rectal cancer[J].International Journal of Molecular Sciences,2016,17(4):568.
[21]BERLANGA JJ,BAASS A,SONENBERG N.Regulation of poly(A) binding protein function in translation:characterization of the Paip2 homolog,Paip2B[J].RNA,2006,12(8):1556-1568.
[22]TANG H,WEI P,CHANG P,et al.Genetic polymorphisms associated with pancreatic cancer survival:a genome-wide association study[J].International Journal of Cancer,2017,141(4):678-686.
[23]MUKHERJEE M,GOSWAMI S.Identification of key deregulated RNA-binding proteins in pancreatic cancer by meta-analysis and prediction of their role as modulators of oncogenesis[J].Frontiers in Cell and Developmental Biology,2021,9:713852.